Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Nantkwest, Inc.

NASDAQ: NKHealthcare / Biotechnology / USA
1.37+0.0100+0.74%Vol 100 1431Y Perf -69.25%
Jan 16th, 2019 16:00
BID1.36 ASK1.37
Open1.35 Previous Close1.36
Pre-Market- After-Trading-
 - -%  - -%
Target Price
3.50 
Analyst Rating
Hold 3.00
Potencial %
155.47 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★+     40.14
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)109 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
9.69 
Earnings Date
11th Mar 2019

Today's Price Range

1.331.44

 

52wk Range

0.93005.47

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Neutral
Performance
1 Month
13.22%
3 Months
-52.43%
6 Months
-55.66%
1 Year
-69.25%
3 Years
-89.00%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
NK1.370.01000.74
AAPL154.941.87001.22
GOOG1 080.973.82000.35
MSFT105.380.37000.35
XOM71.64-0.0300-0.04
WFC48.941.27002.66
JNJ128.04-1.3200-1.02
FB147.54-1.4100-0.95
GE8.980.25002.86
JPM102.500.82000.81
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.80
Current Ratio
3.30
Long Term Debt to Total Capital
0.04
Total Debt to Equity
0.05
Interest Coverage
-321.70
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-199 227.00
EBITDA Margin
-183 194.00
Pre-tax Profit Margin
-161 614.00
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.68
PS Ratios
2 772.91
Price to Cash Flow
-
Price to Free Cash Flow
-1.80
Cash Flow Per Share
-0.80
Price to Tangible Book
0.69
Book Value per Share
2.05
Enterprise Value (in ths.)
34 912
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-50.10
ROE last 12 Months
-51.71
Return on Assets (5Y Avg)
-38.58
ROA last 12 Months
-43.13
Return on Capital (5Y Avg)
-49.91
ROC last 12 Months
-51.24
Return on invested Capital Q
-13.38
Return on invested Capital Y
-38.22
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
40
Revenue per Share
0.00
Revenue Growth 3 Years
-42.13
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.37-0.3018.92
Q01 2018-0.34-0.35-2.94
Q04 2017--0.31-
Q02 2017-0.32-0.299.38
Q01 2017-0.39-0.3023.08
Q02 2016-0.35-0.41-17.14
Q01 2016-0.24-0.38-58.33
Q03 2015-0.07-0.55-685.71
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.3122.50Positive
12/2018 FY-1.3110.88Positive
3/2019 QR-0.3116.22Positive
12/2019 FY-1.4015.15Positive
Next Report Date11th Mar 2019
Estimated EPS Next Report-0.31
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume100 143
Shares Outstanding (in ths.)79 230
Trades Count368
Dollar Volume105 857
Avg. Volume210 777
Avg. Weekly Volume161 010
Avg. Monthly Volume300 557
Avg. Quarterly Volume605 506

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

29%71%

Bearish Bullish

64%36%

Bearish Bullish

73%27%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News